Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
European Journal of Cancer (Oxford, England : 1990)|October 20, 2024
First-line encorafenib plus binimetinib and pembrolizumab for advanced BRAF V600-mutant melanoma: Safety lead-in results from the randomized phase III STARBOARD studyOleksandr Dudnichenko, Konstantin Penkov, Meredith McKean, et al.
Cell Cycle (Georgetown, Tex.)|November 21, 2012
Pro- and anti-apoptotic effects of p53 in cisplatin-treated human testicular cancer are cell context-dependentAlessandra di Pietro, Roelof Koster, Wytske Boersma-van Eck, et al.
The Journal of Clinical Investigation|September 3, 2010
Cytoplasmic p21 expression levels determine cisplatin resistance in human testicular cancerRoelof Koster, Alessandra di Pietro, Hetty Timmer-Bosscha, et al.
Future Oncology (London, England)|March 11, 2022
STARBOARD: encorafenib + binimetinib + pembrolizumab for first-line metastatic/unresectable BRAF V600-mutant melanomaDirk Schadendorf, Reinhard Dummer, Caroline Robert, et al.
Urologic Oncology|April 5, 2023
Avelumab first-line maintenance plus best supportive care (BSC) vs. BSC alone for advanced urothelial carcinoma: JAVELIN Bladder 100 Asian subgroup analysisJae-Lyun Lee, Chirag Desai, Se Hoon Park, et al.
Dermatologic Therapy|November 9, 2010
Electrochemotherapy for cutaneous and subcutaneous tumor lesions: a novel therapeutic approachAlessandro Testori, Giulio Tosti, Chiara Martinoli, et al.
BMJ Oncology|January 31, 2025
Association between neutrophil-to-eosinophil ratio and efficacy outcomes with avelumab plus axitinib or sunitinib in patients with advanced renal cell carcinoma: post hoc analyses from the JAVELIN Renal 101 trialMatthew Tucker, Yu-Wei Chen, Martin H Voss, et al.
Neoplasia (New York, N.Y.)|September 25, 2008
Clinical evaluation of M30 and M65 ELISA cell death assays as circulating biomarkers in a drug-sensitive tumor, testicular cancerEsther C de Haas, Alessandra di Pietro, Kathryn L Simpson, et al.
Cancer Discovery|February 22, 2024
Integrative Analyses of Tumor and Peripheral Biomarkers in the Treatment of Advanced Renal Cell CarcinomaToni K Choueiri, Amber C Donahue, David A Braun, et al.
European Urology|October 18, 2023
Impact of Prior Cytoreductive Nephrectomy on Efficacy in Patients with Synchronous Metastatic Renal Cell Carcinoma Treated with Avelumab plus Axitinib or Sunitinib: Post Hoc Analysis from the JAVELIN Renal 101 Phase 3 TrialMarc-Oliver Grimm, Mototsugu Oya, Toni K Choueiri, et al.
Pageof 4